55.5% were female, 88.8% (8 of 9 patients) had ventricular tachycardia and 11.2% had complete heart block. VT recurred despite initial treatment in 87%. Addition of disease-specific therapy abolished further recurrences in 71% of them. Conclusion: Patients with granulomatous cardiomyopathy usually presents as unexplained ventricular arrhythmias or occasionally atrioventricular nodal block with preserved or compromised ventricular function. It is a syndrome of arrhythmogenic myocarditis with granulomatous lymphadenopathy due to myocardial tuberculosis or cardiac sarcoidosis. This entity is optimally managed with a combination of disease-specific therapy and antiarrhythmic measures.
Is atrial fibrillation an independent predictor of prosthetic heart valve thrombosis Introduction: Prosthetic heart valve thrombosis (PHVT) is an uncommon but serious complication of valve replacement. As compared to developed countries where the reported incidence of PHVT ranges from 0.3% to 3% per year, Indian studies have quoted the incidence to be as high as 6% in the initial 6 months of valve implantation. Previous studies have demonstrated variety of risk factors [compliance to oral anticoagulation (OAC), depressed i n d i a n h e a r t j o u r n a l 6 7 ( 2 0 1 5 ) s 7 2 -s 8 2 M -male, F -female, No -normal, C -compromised, VT -ventricular tachycardia, CHB -complete heart block, S -sarcoidosis, TB -tuberculosis, GIUEgranulomatous inflammation of undetermine etiology, M -mediastinal, C -cervical, P -positive, N -negative, ATT -antituberculous therapy, CS -cardiac sarcoidosis, PDN -prednisolone, Mtx -methotrexate, AAD -antiarrhythmic drug, ICD -implantable cardioverter defibrillator. 
